Stock listing
Adimmune Corporation
Selected listing: 4142 · TWSE · TWD · TW
Adimmune Corporation (TWSE:4142), Health Technology. Latest release Aug 12, 2022: Adimmune : announces financail statements of 2022 second quarter.
- Ticker
- TWSE:4142
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TWSE
- Currency
- TWD
About Adimmune Corporation
The company specializes in the development and production of vaccines and other biological products. Adimmune aims to contribute to public health by providing high-quality immunization solutions.
Latest news from Adimmune Corporation
Adimmune : announces financail statements of 2022 second quarter.
August 12, 2022
Adimmune : To announce the completion status of execution of the stock repurchase
August 9, 2022
Adimmune : The list of the newly elected 21st directors (including independent directors) of the Company
June 29, 2022
Adimmune : The Company's shareholders' meeting approved the release of non-compete restrictions on directors
June 29, 2022
Adimmune : The Company's board of directors re-elected Dr. Chan Chi-Hsien as the chairperson
June 29, 2022
Research Adimmune Corporation
Adimmune Corporation company profile
View the public company page for Adimmune Corporation on 6ix.
Adimmune Corporation news
Read company news and market updates connected to Adimmune Corporation.
Adimmune Corporation investor events
Find investor webinars, events, and replay context for Adimmune Corporation.